The effects of resuscitation with albumin on 90-day mortality in patients with severe sepsis was estimated from five trials (Figure 2), and the heterogeneity was also determined to be non-significant (P = 0.86, I2 = 0%). This evidence concerns the gene ALB and Sepsis.